Some people carry one of the strongest genetic risk factors for Alzheimer's disease yet never develop it, remaining mentally sharp well into their 80s. For years, scientists have wondered what protects these individuals despite their increased genetic vulnerability. Now, researchers at Columbia University have uncovered a biological mechanism that could help explain this remarkable resistance.
Their findings point to a rare genetic mutation that protects the brain's blood vessels from damage, potentially opening a new path toward Alzheimer's treatments. The discovery builds on research the team published two years ago involving APOE ε4, a gene variant strongly associated with Alzheimer's risk. The scientists found that some people carrying APOE ε4 also possess a rare protective mutation in the fibronectin (FN1) gene.
Fibronectin is a protein that helps support the structure of tissues. However, in people with APOE ε4, excessive amounts can accumulate around blood vessels in the brain, potentially compromising a critical protective system known as the blood-brain barrier. The rare FN1 mutation appears to limit this buildup and the damage associated with it.
That earlier discovery suggested an intriguing possibility: What if scientists could develop a treatment that recreates the protection provided by this rare mutation? A new study published in Nature Aging brings that possibility closer by identifying how excess fibronectin damages the brain's protective barrier and revealing potential ways to interrupt the process. "This new study takes us from a genetic clue to a disease mechanism," says Caghan Kizil, the study's corresponding author and professor of neurological sciences in the Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain at Columbia University Vagelos College of Physicians and Surgeons.
"We knew that changes in fibronectin could protect against Alzheimer's, but we didn't know why excess fibronectin was harmful in the first place. This study gives us that detailed mechanism -- and with it, ideas for how to reproduce that natural protection." How an Alzheimer's Risk Gene Weakens the Blood-Brain Barrier The blood-brain barrier serves as a protective boundary between the bloodstream and the brain. Made up of tightly connected cells surrounding the brain's blood vessels, it carefully regulates which substances can enter brain tissue while helping maintain conditions necessary for removing potentially harmful waste.
When this barrier becomes damaged or excessively permeable, substances that would normally be kept out can enter the brain more easily. Such disruptions may contribute to inflammation and other processes involved in neurological diseases, including Alzheimer's. To investigate the role of fibronectin, the Columbia team combined several advanced research approaches.
Extract — continue reading at the source.
